GenEmbryomics Withdraws Nasdaq IPO Plan
30 Apr 2025
US$ 20.00
GenEmbryomics Ltd (GenEmbryomics), an Australian medical technology company backed by venture capital firm Artesian,...
Related Publications
KKR & Co Inc (KKR) announced its intention to launch a tender offer to privatise Taiyo Holdings Co Ltd (Taiyo), at a...
TPG NewQuest has led the A$360 m (US$248 m) funding of a continuation vehicle for Vets Central Pty Ltd (Vets Central),...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.